Successful Use of Bivalirudin for Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 5, 2003, Pages 632-635

  Gordon, George ^a   Rastegar, Hassan ^a   Schumann, Roman ^a   Deiss Shrem, Judith ^a   Denman, William ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Bivalirudin; Cardiac surgery; Cardiopulmonary bypass; Heparin induced thrombocytopenia

Indexed keywords

HEPARIN; HIRULOG; ISOFLURANE; LEPIRUDIN; PANCURONIUM; PROPOFOL; SUFENTANIL;

ADULT; ANESTHESIA INDUCTION; ANTICOAGULATION; AORTA VALVE REGURGITATION; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BOLUS INJECTION; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0142094653     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(03)00210-6     Document Type: Article

References (35)

1. Natelson EA, Lynch EC, Alfrey CP Jr: Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy. Ann Intern Med 71:1121-1125, 1969
2. Weismann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219-227, 1958
3. Rhodes GR, Dixon RH, Silver D: Heparin-induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 136:409-416, 1973
4. Bell WR, Tomasulo PA, Alving BM, et al: Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med 85:155-160, 1976
5. Maraganore JM, Adelman BA: Hirulog: A direct thrombin inhibitor for the management of acute coronary syndromes. Coron Artery Dis 7:438-448, 1996
6. Robson R: The use of bivalirudin in patients with renal impairment. J Invas Cardiol 12:33F-36F, 2000 (suppl)
7. Brieger DB, Mak KH, Kottke-Marchant K, et al: Heparin-induced thrombocytopenia. J Am Coll Cardiol 31:1449-1459, 1998
8. Warkentin TE, Levine MN, Hirsh J, et al: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335, 1995
9. Warkentin TE, Kelton JG: A 14-year study of heparin-induced thrombocytopenia. Am J Med 101:502-507, 1996
10. Demers C, Ginsberg JS, Brill-Edwards P, et al: Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood 78:2194-2197, 1991
11. Cole CW, Fournier LM, Bormanis J: Heparin-associated thrombocytopenia and thrombosis: Optimal therapy with ancrod. Can J Surg 33:207-210, 1990
12. Zulys VJ, Teasdale SJ, Michel ER, et al: Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 71:870-877, 1989
13. Lathan LO, Staggers SL: Ancrod: The use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: Nursing management. Heart Lung 25:451-460, 1996
14. Lewis BE, Leya FS, Wallis D, Grassman E: Failure of ancrod in the treatment of heparin-induced arterial thrombosis. Can J Cardiol 10:559-561, 1994
15. Olin DA, Urdaneta F, Lobato EB: Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth 14:707-709, 2000
16. Fernandes P, Mayer R, MacDonald JL, et al: Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: A clinical evaluation of six cases. Perfusion 15: 531-539, 2000
17. Christiansen S, Geiger A, Splittgerber FH, et al: Aortocoronary vein bypass in a patient with type II heparin-associated thrombocytopenia: A case report. Int J Angiol 7:268-270, 1998
18. Chong BH, Ismail F, Cade J, et al: Heparin-induced thrombocytopenia: studies with a new low-molecular-weight heparinoid, Org 10172. Blood 73:1592-1596, 1989
19. Magnani HN: Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 70:554-561, 1993
20. Kikta MJ, Keller MP, Humphrey PW, et al: Can low-molecular-weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Surgery 114:705-710, 1993
21. Ariano RE, Bhattacharya SK, Moon M, et al: Failure of danaparoid anticoagulation for cardiopulmonary bypass. J Thorac Cardiovasc Surg 119:167-168, 2000
22. Koster A, Hansen R, Kuppe H, et al: Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients. J Cardiothorac Vasc Anesth 14:243-248, 2000
23. Riess FC, Kormann J, Poetzsch B: Recombinant hirudin as anticoagulant during cardiopulmonary bypass. Anesthesiology 93: 1551-1552, 2000
24. Johnston N, Jessen ME, DiMaio M, et al: The emergency use of recombinant hirudin in cardiopulmonary bypass. J Extra Corpor Technol 31:211-215, 1993
25. Fischer KG, Van de Loo A, Böhler J: Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Kidney Int 56:S46-S50, 1999
26. Vanholder RC, Camez AA, Veys NM, et al: Recombinant hirudin: A specific thrombin-inhibiting anticoagulant for hemodialysis. Kidney Int 45:1754-59, 1994
27. Fabrizio MC: Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass. J Extra Corpor Technol 33:117-125, 2001
28. Despotis GJ, Hogue CW, Saleem R, et al: The relationship between hirudin and activated clotting time: Implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery. Anesth Analg 93:28-32, 2001
29. Koster A, Hansen R, Grauhan O, et al: Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II. J Cardiothroac Vasc Anesth 14:249-252, 2000
30. Koster A, Merkle F, Hansen R, et al: Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems. Anesth Analg 91:265-269, 2000
31. Ide H, Fujiki T, Sato M, et al: Off-pump coronary artery bypass for a heparin-allergic patient. Jpn J Thorac Cardiovasc Surg 49:250-254, 2001
32. Arnoletti JP, Whitman GJ: Heparin-induced thrombocytopenia in coronary bypass surgery. Ann Thorac Surg 68:576-578, 1999
33. Swan SK, Hursting MJ: The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 20:318-329, 2000
34. Koster A, Kukucka M, Bach F, et al: Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban. Anesthesiology 94:245-251, 2001
35. Bittl JA, Chaitman BR, Feit F, et al: Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J 142:952-959, 2001